Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
DiaMedica Therapeutics Inc
DMACCurrent price
2.66 USD
+0.13 USD (+5.14%)
Last closed
2.59 USD
Company
www.diamedica.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
98 300 080 USD
Yield for 12 month
+103.05 %
Week
Month
Year
DMAC
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. The company develops treatments for neurological disorders and cardio-renal disease. Its lead candidate is DM199, a pharmaceutically active recombinant form of the kallikrein-1 protein for the treatment of acute ischemic stroke and other vascular diseases. It is also developing DM300 that is in preclinical stage of development for the treatment of inflammatory diseases. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. Address: Two Carlson Parkway, Minneapolis, MN, United States, 55447
Analytics
WallStreet Target Price
8.33 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
-5 157 000 USD
Last Quarter
-4 741 000 USD
Key Figures DMAC
1 year
3 years
5 years
10 years
EBITDA
-19 364 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-25.47 %
PEG Ratio
–
Return On Equity TTM
-39.62 %
Wall Street Target Price
8.33 USD
Revenue TTM
–
Book Value
1.47 USD
Revenue Per Share TTM
–
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings Share
-0.6 USD
Diluted Eps TTM
-0.6 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics DMAC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DMAC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
15.11.2018
Dividend Date
15.11.2018
Stock Valuation DMAC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-2.581
Price Book MRQ
1.7261
Financials DMAC
1 year
3 years
5 years
10 years
| Results | 2019 | Dynamics |
Technical indicators DMAC
For 52 weeks
1.27 USD
4.75 USD
50 Day MA
2.37 USD
Shares Short Prior Month
244 337
200 Day MA
2.54 USD
Short Ratio
4.41
Shares Short
244 175
Short Percent
0.71 %
Google
Apple
Facebook